WallStreetZenWallStreetZen

NASDAQ: GLYC
Glycomimetics Inc Earnings & Revenue

GLYC past revenue growth

How has GLYC's revenue growth performed historically?
Company
-86.67%
Industry
169.3%
Market
17.86%
GLYC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GLYC's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

GLYC earnings and revenue history

Current Revenue
$10.0k
Current Earnings
-$36.9M
Current Profit Margin
-368,994.2%

GLYC Return on Equity

Current Company
-73.1%
Current Industry
-63.4%
Current Market
188%
GLYC's Return on Equity (-73.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GLYC announces earnings.

GLYC Return on Assets

Current Company
-64.4%
Current Industry
3.2%
GLYC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GLYC Return on Capital Employed

Current Company
-95.89%
Current Industry
19.9%
GLYC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GLYC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GLYC$10.00k-$35.89M-$36.90M-99.97%N/A
DRTS$0.00-$21.53M-$29.16MN/AN/A
ABEO$3.50M-$50.57M-$54.19M+3.14%N/A
INMB$224.00k-$27.43M-$27.43M+177.92%N/A
CAPR$25.18M-$21.22M-$22.29M+72.02%N/A

GLYC earnings dates

Next earnings date
May 1, 2024

Glycomimetics Earnings & Revenue FAQ

What were GLYC's earnings last quarter?

On Invalid Date, Glycomimetics (NASDAQ: GLYC) reported Q4 2023 earnings per share (EPS) of -$0.14, up 26.32% year over year. Total Glycomimetics earnings for the quarter were -$9.08 million. In the same quarter last year, Glycomimetics's earnings per share (EPS) was -$0.19.

If you're new to stock investing, here's how to buy Glycomimetics stock.

What was GLYC's earnings growth in the past year?

As of Q1 2024, Glycomimetics's earnings has grown year over year. Glycomimetics's earnings in the past year totalled -$36.90 million.

What is GLYC's earnings date?

Glycomimetics's earnings date is Invalid Date. Add GLYC to your watchlist to be reminded of GLYC's next earnings announcement.

What was GLYC's revenue last quarter?

On Invalid Date, Glycomimetics (NASDAQ: GLYC) reported Q4 2023 revenue of $10.00 thousand up Infinity% year over year. In the same quarter last year, Glycomimetics's revenue was $0.00.

What was GLYC's revenue growth in the past year?

As of Q1 2024, Glycomimetics's revenue has grown -86.67% year over year. This is 255.96 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Glycomimetics's revenue in the past year totalled $10.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.